Table 2.
Prognostic Models for 6-Month Glasgow Outcome Scale Extended (GOSE) After Mild TBI: Model Performance (N = 2376)
Core model | Clinical model | Clinical +early symptoms (RPQ) | Clinical +CT | Clinical +Biomarkers | Clinical+ early symptoms, CT, biomarkers | Clinical +2-3–week symptoms [subset n = 640] | |
---|---|---|---|---|---|---|---|
Ordinal GOSE (1-8) | |||||||
Nagelkerke R2 (optimism-corrected) | 0.18 | 0.21 | 0.22 | 0.24 | 0.23 | 0.26 | 0.21 |
C (optimism- corrected) 95% CI | 0.68 [0.68-0.70] | 0.70 [0.69-0.71] | 0.71 [0.69-0.72] | 0.71 [0.70-0.72] | 0.71 [0.70 -0.72] | 0.72 [0.71-0.73] | 0.74 [0.71-0.78] |
C (optimism-corrected) for different cutoffs | |||||||
GOSE = 81 | 0.69 | 0.70 | 0.72 | 0.71 | 0.71 | 0.73 | 0.75 |
GOSE ≥72 | 0.73 | 0.74 | 0.75 | 0.75 | 0.76 | 0.76 | 0.76 |
GOSE ≥53 | 0.79 | 0.80 | 0.80 | 0.80 | 0.82 | 0.81 | 0.69** |
Only 10 outcome events.
Complete vs. incomplete recovery/death.
Good recovery vs. disability/death.
Moderate disability/good recovery (“favorable”) vs. severe disability/death (“unfavorable”).
TBI, traumatic brain injury; RPQ, Rivermead Post-Concussion Symptoms Questionnaire; CT, computed tomography; C, concordance index; CI, confidence Interval.